col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Springer Science and Business Media LLC: British Journal of Cancer
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―01 Inequalities in the decline and recovery of pathological cancer diagnoses during the first six months of the COVID-19 pandemic: a population-based study Ashleigh C. Hamilton, David W. Donnelly, Maurice B. Loughrey, Richard C. Turkington, Colin Fox, Deirdre Fitzpatrick, et al. (+3)
2 [GO] 2021―Jun―23 Publisher Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study Rajiv V. Dave, Baek Kim, Alona Courtney, Rachel O’Connell, Tim Rattay, Vicky P. Taxiarchi, et al. (+16)
3 [GO] 2021―Jun―16 Mortality of patients with solid and haematological cancers presenting with symptoms of COVID-19 with vs without detectable SARS-COV-2: a French nationwide prospective cohort study Souad Assaad, Philippe Zrounba, Claire Cropet, Jean-Yves Blay
4 [GO] 2021―May―11 Correction: Effects of cancer screening restart strategies after COVID-19 disruption Lindy M. Kregting, Sylvia Kaljouw, Lucie de Jonge, Erik E. L. Jansen, Elisabeth F. P. Peterse, Eveline A. M. Heijnsdijk, et al. (+3)
5 [GO] 2021―May―11 Impact of active cancer on COVID-19 survival: a matched-analysis on 557 consecutive patients at an Academic Hospital in Lombardy, Italy Alexia F. Bertuzzi, Michele Ciccarelli, Andrea Marrari, Nicolò Gennaro, Andrea Dipasquale, Laura Giordano, et al. (+4)
6 [GO] 2021―May―10 COVID-19 and the multidisciplinary care of patients with lung cancer: an evidence-based review and commentary Thomas Round, Veline L’Esperance, Joanne Bayly, Kate Brain, Lorraine Dallas, John G. Edwards, et al. (+9)
7 [GO] 2021―Apr―14 Anticipated help-seeking for cancer symptoms before and after the coronavirus pandemic: results from the Onco-barometer population survey in Spain Dafina Petrova, Marina Pollán, Miguel Rodriguez-Barranco, Dunia Garrido, Josep M. Borrás, Maria-José Sánchez
8 [GO] 2021―Apr―12 Correction: Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study Rajiv V. Dave, Baek Kim, Alona Courtney, Rachel O’Connell, Tim Rattay, Vicky P. Taxiarchi, et al. (+16)
9 [GO] 2021―Mar―25 COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic Alvin J. X. Lee, Karin Purshouse
10 [GO] 2021―Mar―25 Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study Rajiv V. Dave, Baek Kim, Alona Courtney, Rachel O’Connell, Tim Rattay, Vicky P. Taxiarchi, et al. (+16)
11 [GO] 2021―Mar―15 Effects of cancer screening restart strategies after COVID-19 disruption Lindy M. Kregting, Sylvia Kaljouw, Lucie de Jonge, Erik E. L. Jansen, Elleke F. P. Peterse, Eveline A. M. Heijnsdijk, et al. (+3)
12 [GO] 2021―Mar―15 Correction to: The impact of COVID-19 on systemic anticancer treatment delivery in Scotland Mark A. Baxter, John Murphy, David Cameron, Judith Jordan, Christine Crearie, Christina Lilley, et al. (+7)
13 [GO] 2021―Mar―15 Recovering cancer screening in the pandemic: strategies and their impacts David S. Morrison
14 [GO] 2021―Feb―09 Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses Alejandra Castanon, Matejka Rebolj, Francesca Pesola, Peter Sasieni
15 [GO] 2021―Feb―09 Impact of COVID-19 pandemic on eye cancer care in United Kingdom Haoyu Wang, Mohammed Elsheikh, Kenneth Gilmour, Victoria Cohen, Mandeep S. Sagoo, Bertil Damato, et al. (+8)
16 [GO] 2021―Feb―09 Urological cancer patients receiving treatment during COVID-19: a single-centre perspective Sophie Therese Williams, Salma El Badri, Syed Anwer Hussain
17 [GO] 2021―Feb―09 The tele-transition of toxicity management in routine oncology care during the severe acute respiratory syndrome (SARS-CoV-2) pandemic Marika Rasschaert, Pieterjan Vanclooster, Tim Mertens, Ella Roelant, Katrien Lesage, Hans Prenen, et al. (+6)
18 [GO] 2021―Feb―03 More light on cancer and COVID-19 reciprocal interaction Patrick Brest, Baharia Mograbi, Paul Hofman, Gerard Milano
19 [GO] 2021―Feb―02 The impact of COVID-19 on systemic anticancer treatment delivery in Scotland Mark A. Baxter, John Murphy, David Cameron, Judith Jordan, Christine Crearie, Christina Lilley, et al. (+7)
20 [GO] 2021―Jan―04 Time to revisit the use of G-CSF after allogeneic haematopoietic cell transplantation in COVID-19 era? Alexandre E. Malek
21 [GO] 2020―Dec―10 Severity of COVID-19 in children with cancer: Report from the United Kingdom Paediatric Coronavirus Cancer Monitoring Project Gerard C. Millen, Roland Arnold, Jean-Baptiste Cazier, Helen Curley, Richard G. Feltbower, Ashley Gamble, et al. (+8)
22 [GO] 2020―Dec―07 COVID-19 vaccine race: watch your step for cancer patients Raphaelle Fanciullino, Joseph Ciccolini, Gerard Milano
23 [GO] 2020―Nov―30 The COVID-19 pandemic and impact on breast cancer diagnoses: what happened in England in the first half of 2020 Toral Gathani, Gill Clayton, Emma MacInnes, Kieran Horgan
24 [GO] 2020―Nov―03 Reply to Comment on “The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic Christopher M. Jones, Ganesh Radhakrishna, Katharine Aitken, John Bridgewater, Pippa Corrie, Martin Eatock, et al. (+12)
25 [GO] 2020―Nov―03 Comment on “Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position” Ali Arshad, Ashley Dennison, Mark A. Taylor, Andrew Cook, John N. Primrose
26 [GO] 2020―Jul―23 Reflections on the upsurge of virtual cancer conferences during the COVID-19 pandemic Valerie Speirs
27 [GO] 2020―Jul―08 Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position Christopher M. Jones, Ganesh Radhakrishna, Katharine Aitken, John Bridgewater, Pippa Corrie, Martin Eatock, et al. (+12)
28 [GO] 2020―Jun―26 COVID-19 and cancer research Adrian L. Harris
29 [GO] 2020―Jun―22 Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy Kamal S. Saini, Carlo Lanza, Marco Romano, Evandro de Azambuja, Javier Cortes, Begoña de las Heras, et al. (+7)
30 [GO] 2020―Jun―16 Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome? Oliver J. Pickles, Lennard Y. W. Lee, Thomas Starkey, Luke Freeman-Mills, Anna Olsson-Brown, Vinton Cheng, et al. (+4)
31 [GO] 2020―May―14 Lessons to Europe from China for cancer treatment during the COVID-19 pandemic Ling Peng, Jin-Song Yang, Justin Stebbing
32 [GO] 2020―Apr―20 Prevention and control strategies for the diagnosis and treatment of cancer patients during the COVID-19 pandemic Juan Tan, Chao Yang
33 [GO] 2020―Apr―17 Caring for our cancer patients in the wake of COVID-19 Karim Hussien El-Shakankery, Joanna Kefas, Shanthini Mary Crusz


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.005 sec